Civica Rx and Blue Cross Blue Shield Companies Join Forces

The Blue Cross Blue Shield Association, 18 independent and locally-operated Blue Cross and Blue Shield companies and Civica Rx announced today their partnership to create a new subsidiary dedicated to lowering the cost of select generic drugs. The subsidiary is being formed in response to the impact of high drug costs on the health of […]

Civica Rx Partners with Thermo Fisher Scientific

Civica Rx today announced it has signed a long-term agreement with Thermo Fisher Scientific to develop and manufacture medications with Civica as the owner of the regulatory pathway. By working with Thermo Fisher to develop Civica-owned Abbreviated New Drug Applications (ANDAs), Civica will secure the manufacture of certain essential medications, further mitigating the risk of […]

Civica Rx ANDA Statement

Civica Rx today announced that it is interested in talking to generic drug manufacturers who are considering retiring or withdrawing their Abbreviated New Drug Applications (ANDAs) for essential medicines that are at risk of being in short supply. Periodically, the FDA withdraws approvals of ANDAs due to manufacturer inactivity. According to published reports, the FDA […]

Civica Rx and Hikma Announce Shipments of Heparin and Seven other Essential Injectable Medicines

Civica Rx and Hikma Pharmaceuticals, the multinational generic pharmaceutical company, today announced imminent shipments of Heparin Sodium Injection, USP, and seven other essential injectable medicines, with additional products to follow in the near term in the US through its affiliate, Hikma Pharmaceuticals USA Inc. Today’s announcement comes as industry experts work to avoid an extended […]

Generic Drug Shortages: A Week of Positive Momentum

Important steps taken to address generic drug shortages – a problem that has become a national crisis that impacts the U.S. medical community daily. The last week of October 2019 proved to be an active one on the subject of generic drug shortages and the urgent need to address them. Civica applauds the focus on […]

Civica Rx and Exela Pharma Sciences Join Forces

Civica Rx and Exela Pharma Sciences Join Forces to Provide Sodium Bicarbonate to Hospitals Across the U.S.  The partnership will help stabilize supply of a vital medicine used daily for emergency care. Civica Rx  and Exela Pharma Sciences, today announce a long-term agreement to manufacture and supply Civica’s growing membership of U.S. health systems with […]

Civica Rx Celebrates Its First Birthday!

Overheard at a recent Congressional Hearing on the reliability of the global generic drug supply chain: “I think it is fascinating to watch what the private sector hospitals in the United States are doing…they formed a nonprofit called Civica Rx in response to persistent shortages of vital life-saving medicines…and they are doing direct contracting with trustworthy manufacturers…with long-term […]

Hikma and Civica Rx Sign Long-term Agreement

Hikma Pharmaceuticals PLC, the multinational generic pharmaceutical company and Civica Rx, today announce a five-year agreement to manufacture and supply Civica’s growing membership of US health systems with medications that are often in short supply in US hospitals. Under the agreement, Hikma will produce 14 essential sterile injectable medications for Civica as a private label […]

Vizient Announces It Will Help Civica Reduce Drug Shortages

Vizient, based in Irving Texas, will provide insights into purchasing patterns and provider needs through their analytics and data capabilities, helping Civica anticipate gaps in drug availability and affordability. “We applaud Vizient for helping to find innovative ways to reduce drug shortages through their analytics and data expertise,” said Martin VanTrieste, Civica CEO.  “The more […]